CAS RN: 76272-36-1
3-AMINO-8-BENZYL-8-AZABICYCLO[3.2.1]OCTANE (3-EXO)-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260120
250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 76272-36-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
76272-36-1 / (1R,5S)-8-benzyl-8-azabicyclo[3.2.1]octan-3-amine
Standard CAS: 76272-36-1
Multi CAS: Yes
Basic Information
copy
CAS
76272-36-1 copy
Multi CAS
Yes copy
Molecular Formula
C14H20N2 copy
Molecular Weight
216.320000 copy
Exact Mass
216.162649 copy
InChI
InChI=1S/C14H20N2/c15-12-8-13-6-7-14(9-12)16(13)10-11-4-2-1-3-5-11/h1-5,12-14H,6-10,15H2/t12?,13-,14+ copy
InChIKey
TZWXPIKAEAYGPF-AGUYFDCRSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
16 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.57 copy
Rotatable bonds
2 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
66 copy
TPSA
29.26 copy
LogP / Solubility
WLOGP
2.14 copy
MLOGP
1.89 copy
XLogP3
2 copy
Consensus LogP
2.01 copy
Log S (ESOL)
-2.68 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.88 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-3.08 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.52 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
4.5 copy